22nd Century Group Stock Price, News & Analysis (NYSEAMERICAN:XXII)

$2.32 -0.04 (-1.69 %)
(As of 11/22/2017 09:34 AM ET)
Previous Close$2.36
Today's Range$2.31 - $2.45
52-Week Range$0.81 - $3.50
Volume2.64 million shs
Average Volume2.17 million shs
Market Capitalization$279.40 million
P/E RatioN/A
Dividend YieldN/A
Beta2.89

About 22nd Century Group (NYSEAMERICAN:XXII)

22nd Century Group logo22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.


Industry, Sector and Symbol:
  • Industry: Environmental Biotechnology
  • Sub-Industry: Cannabis
  • Sector: N/A
  • Symbol: NYSEAMERICAN:XXII
  • Previous Symbol: AMEX:XXII
  • CUSIP: N/A
  • Web: www.xxiicentury.com
Profitability:
  • Trailing EPS: ($0.13)
  • Net Margins: -86.10%
  • Return on Equity: -57.55%
  • Return on Assets: -49.40%
Misc:
  • Outstanding Shares: 123,560,000
 

Frequently Asked Questions for 22nd Century Group (NYSEAMERICAN:XXII)

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XXII."

How were 22nd Century Group's earnings last quarter?

22nd Century Group Inc (NYSEAMERICAN:XXII) released its quarterly earnings results on Thursday, November, 9th. The biotechnology company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The biotechnology company had revenue of $4.53 million for the quarter, compared to analysts' expectations of $5.09 million. 22nd Century Group had a negative net margin of 86.10% and a negative return on equity of 57.55%. The firm's revenue for the quarter was up 46.1% on a year-over-year basis. During the same quarter last year, the firm earned ($0.03) earnings per share. View 22nd Century Group's Earnings History.

Where is 22nd Century Group's stock going? Where will 22nd Century Group's stock price be in 2017?

1 equities research analysts have issued 12-month price objectives for 22nd Century Group's shares. Their predictions range from $11.50 to $11.50. On average, they expect 22nd Century Group's stock price to reach $11.50 in the next twelve months. View Analyst Ratings for 22nd Century Group.

What are Wall Street analysts saying about 22nd Century Group stock?

Here are some recent quotes from research analysts about 22nd Century Group stock:

  • 1. According to Zacks Investment Research, "22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. " (10/18/2017)
  • 2. Chardan Capital analysts commented, "We expect 22nd Century to report Q4 results this week. Our revenue estimate for the quarter is $3.1 million, equivalent to Q3 results. For the full year this results in revenue of $12 million. We expect the company on its earnings call to focus on recent communications with the FDA regarding its PMTA (Premarket Tobacco Product Applications), the MRTP (Modified Risk Tobacco Product) applications and a path forward for X-22. Earlier this month the FDA granted a guidance meeting to discuss X-22 and the ways 22nd Century could attempt to win approval for X-22 as a prescription-based aid for smoking cessation. The company has also received written feedback on the MRTP application for Brand A, the company's very low nicotine (VLN) cigarette. As we progress through the year we expect additional milestones to be reached on 22nd Century's attempt to use its proprietary technology to create VLN products for the smoking cessation market." (3/7/2017)

Are investors shorting 22nd Century Group?

22nd Century Group saw a decrease in short interest in October. As of October 31st, there was short interest totalling 9,677,128 shares, a decrease of 2.9% from the October 13th total of 9,966,801 shares. Based on an average daily trading volume, of 4,425,009 shares, the days-to-cover ratio is currently 2.2 days. Approximately 9.1% of the company's shares are short sold.

Who are some of 22nd Century Group's key competitors?

Who are 22nd Century Group's key executives?

22nd Century Group's management team includes the folowing people:

  • Henry Sicignano III, President, Chief Executive Officer, Director (Age 48)
  • John T. Brodfuehrer, Chief Financial Officer, Treasurer (Age 58)
  • Thomas L. James Esq., Vice President, General Counsel, Secretary (Age 57)
  • Paul Rushton Ph.D., Vice President - Plant Biotechnology (Age 53)
  • Michael R. Moynihan Ph.D., Vice President - Research & Development (Age 63)
  • James W. Cornell, Non-Executive Independent Chairman of the Board (Age 58)
  • Nora B. Sullivan, Director (Age 58)
  • Joseph Alexander Dunn Ph.D., Independent Director (Age 62)
  • Richard M. Sanders, Independent Director (Age 62)

Who owns 22nd Century Group stock?

22nd Century Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (0.10%), Advisor Group Inc. (0.07%), Bristol Advisors LLC (0.07%) and Wells Fargo & Company MN (0.07%). Company insiders that own 22nd Century Group stock include John T Brodfuehrer and Michael Robert Moynihan. View Institutional Ownership Trends for 22nd Century Group.

Who bought 22nd Century Group stock? Who is buying 22nd Century Group stock?

22nd Century Group's stock was purchased by a variety of institutional investors in the last quarter, including Bristol Advisors LLC, Wells Fargo & Company MN, Bank of New York Mellon Corp and Advisor Group Inc.. View Insider Buying and Selling for 22nd Century Group.

How do I buy 22nd Century Group stock?

Shares of 22nd Century Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 22nd Century Group's stock price today?

One share of 22nd Century Group stock can currently be purchased for approximately $2.32.

How big of a company is 22nd Century Group?

22nd Century Group has a market capitalization of $279.40 million.

How can I contact 22nd Century Group?

22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The biotechnology company can be reached via phone at +1-716-2701523.


MarketBeat Community Rating for 22nd Century Group (NYSEAMERICAN XXII)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  101 (Vote Outperform)
Underperform Votes:  89 (Vote Underperform)
Total Votes:  190
MarketBeat's community ratings are surveys of what our community members think about 22nd Century Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for 22nd Century Group (NYSEAMERICAN:XXII)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.50

Consensus Price Target History for 22nd Century Group (NYSEAMERICAN:XXII)

Price Target History for 22nd Century Group (NYSEAMERICAN:XXII)

Analysts' Ratings History for 22nd Century Group (NYSEAMERICAN:XXII)

Show:
DateFirmActionRatingPrice TargetDetails
10/16/2017Chardan CapitalBoost Price TargetBuy$3.50 -> $11.50View Rating Details
(Data available from 11/22/2015 forward)

Earnings

Earnings History and Estimates Chart for 22nd Century Group (NYSEAMERICAN:XXII)

Earnings by Quarter for 22nd Century Group (NYSEAMERICAN:XXII)

Earnings History by Quarter for 22nd Century Group (NYSEAMERICAN XXII)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.02)($0.03)$5.09 million$4.53 millionViewN/AView Earnings Details
5/10/2016Q1($0.03)($0.04)$3.02 millionViewN/AView Earnings Details
11/9/2015Q3($0.03)($0.04)$2.67 millionViewN/AView Earnings Details
8/4/2015Q215($0.02)($0.02)$1.30 million$2.31 millionViewN/AView Earnings Details
2/6/2015($0.03)($0.09)ViewN/AView Earnings Details
11/14/2014Q314($0.03)($0.05)$0.06 millionViewN/AView Earnings Details
8/14/2014($0.03)($0.03)$0.02 millionViewN/AView Earnings Details
5/2/2014($0.03)($0.09)$0.45 millionViewN/AView Earnings Details
1/30/2014Q4($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for 22nd Century Group (NYSEAMERICAN:XXII)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for 22nd Century Group (NYSEAMERICAN:XXII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for 22nd Century Group (NYSEAMERICAN XXII)

Insider Trades by Quarter for 22nd Century Group (NYSEAMERICAN:XXII)
Institutional Ownership by Quarter for 22nd Century Group (NYSEAMERICAN:XXII)

Insider Trades by Quarter for 22nd Century Group (NYSEAMERICAN XXII)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/29/2017Michael Robert MoynihanVPSell50,000$2.67$133,500.00View SEC Filing  
7/31/2017Michael Robert MoynihanVPSell29,532$2.00$59,064.00View SEC Filing  
6/8/2017Michael Robert MoynihanVPSell20,468$2.00$40,936.00View SEC Filing  
10/31/2016Michael Robert MoynihanVPSell100,000$1.28$128,000.00View SEC Filing  
3/29/2016John T BrodfuehrerCFOBuy12,500$0.77$9,625.00View SEC Filing  
11/3/2015Michael Robert MoynihanVPSell50,000$1.40$70,000.00View SEC Filing  
6/30/2015Joseph PandolfinoDirectorSell91,178$0.95$86,619.10View SEC Filing  
12/31/2014Joseph PandolfinoDirectorSell105,124$1.65$173,454.60View SEC Filing  
12/26/2014Joseph PandolfinoDirectorSell41,722$1.54$64,251.88View SEC Filing  
12/22/2014Joseph PandolfinoDirectorSell52,683$1.60$84,292.80View SEC Filing  
12/17/2014Joseph PandolfinoDirectorSell75,768$1.62$122,744.16View SEC Filing  
12/11/2014Joseph PandolfinoDirectorSell67,836$1.65$111,929.40View SEC Filing  
5/9/2014Richard M SandersDirectorBuy20,000$2.23$44,600.00View SEC Filing  
4/23/2014Michael Robert MoynihanVPSell100,000$2.44$244,000.00View SEC Filing  
3/12/2014Joseph PandolfinoCEOSell95,000$5.73$544,350.00View SEC Filing  
12/10/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.55$15,500.00View SEC Filing  
12/3/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.35$13,500.00View SEC Filing  
11/19/2013Clearwater Partners, LlcMajor ShareholderSell30,074$1.09$32,780.66View SEC Filing  
11/13/2013Clearwater Partners, LlcMajor ShareholderSell11,826$0.98$11,589.48View SEC Filing  
11/11/2013Clearwater Partners, LlcMajor ShareholderSell7,100$1.03$7,313.00View SEC Filing  
11/7/2013Clearwater Partners, LlcMajor ShareholderSell9,000$1.15$10,350.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for 22nd Century Group (NYSEAMERICAN XXII)

Source:

Social Media

Social activity is not available for this stock.

Financials

Chart

22nd Century Group (NYSEAMERICAN XXII) Chart for Wednesday, November, 22, 2017
Loading chart…

This page was last updated on 11/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.